IL-6 trans-signaling has been implicated in the pathogenesis of numerous inflammatory conditions and malignancies, the latter including those to which ADAM17 has also been associated with, namely CRC, pancreatic cancer and lung cancer [29,97,213,214,215,216,217]. This evidence concerns the gene ADAM17 and colorectal carcinoma.